Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Point-of-care testing detection methods for COVID-19
COVID-19 is an acute respiratory disease caused by SARS-CoV-2, which has high
transmissibility. People infected with SARS-CoV-2 can develop symptoms including cough …
transmissibility. People infected with SARS-CoV-2 can develop symptoms including cough …
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
Z He, L Ren, J Yang, L Guo, L Feng, C Ma, X Wang… - The Lancet, 2021 - thelancet.com
Background Wuhan was the epicentre of the COVID-19 outbreak in China. We aimed to
determine the seroprevalence and kinetics of anti-SARS-CoV-2 antibodies at population …
determine the seroprevalence and kinetics of anti-SARS-CoV-2 antibodies at population …
Changes in SARS-CoV-2 spike versus nucleoprotein antibody responses impact the estimates of infections in population-based seroprevalence studies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody
responses to the spike (S) protein monomer, S protein native trimeric form, or the …
responses to the spike (S) protein monomer, S protein native trimeric form, or the …
The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
M Infantino, M Pieri, M Nuccetelli, V Grossi… - International …, 2021 - Elsevier
Background and aims SARS-CoV-2 antibody assays are relevant in managing the COVID-
19 pandemic, providing valuable data on the immunization status of the population …
19 pandemic, providing valuable data on the immunization status of the population …
A comparative review of immunoassays for COVID-19 detection
Introduction: The gold standard for diagnosis of coronavirus disease 2019 (COVID-19) is
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse …
Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies
NZ Zabidi, HL Liew, IA Farouk, A Puniyamurti, AJW Yip… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …
Diagnosis for COVID-19: current status and future prospects
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19), a respiratory illness
caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its …
caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its …
Diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic …
S Younes, H Al-Jighefee, F Shurrab, DW Al-Sadeq… - Microorganisms, 2021 - mdpi.com
To support the deployment of serology assays for population screening during the COVID-
19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG …
19 pandemic, we compared the performance of three fully automated SARS-CoV-2 IgG …
Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
V Sasisekharan, N Pentakota… - Proceedings of the …, 2021 - National Acad Sciences
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection during the current pandemic remains a field of immense interest and active …
infection during the current pandemic remains a field of immense interest and active …